Multimodal Intervention for Early Chronic Kidney Disease in Young People: Dysbiosis and Inflammation (CKD)
Starting soon · Not applicable · Has a placebo group
Conditions studied: Exercise, Diet Interventions, Symbiotic, CKD Stage 1, CKD Stage 3, CKD Stage 2
In brief
Chronic kidney disease (CKD) is a progressive condition associated with substantial morbidity, mortality, and healthcare costs. Early detection and timely intervention are critical to modify disease trajectory, particularly in adolescents and young adults. Emerging evidence supports the role of the gut-kidney axis in CKD progression, whereby intestinal dysbiosis contributes to systemic inflammation and accumulation of microbiota-derived uremic toxins. This randomized controlled clinical trial aims to evaluate whether a multimodal intervention consisting of a controlled diet, structured exercise, and a symbiotic administered for 180 days improves uremic toxin burden, systemic inflammation, and early renal outcomes compared with standard care plus placebo.
Key facts
- Study ID
- NCT07483697
- Run by
- Centenario Hospital Miguel Hidalgo
- People needed
- 200
- Starts
- 2026-04-25
- Expected to finish
- 2026-11-03
- Last updated by the study team
- 2026-03-19
Who can join
Age: 14 and older, up to 35. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Persistent albuminuria (ACR >30 and <300 mg/g).
- Estimated GFR >60 mL/min/1.73 m².
- No identifiable secondary cause of kidney disease.
You may not qualify if…
- Hypoalbuminemia.
- Nephrotic syndrome.
- Persistent macroalbuminuria (ACR >300 mg/g).
- Secondary or hereditary kidney disease.
Where it is running
- Instituto de Atención Integral de Enfermedades Renales del Estado de Aguascalientes — Aguascalientes, Aguascalientes, Mexico
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.